Insurance Lags as Cancer Care Comes i...

Insurance Lags as Cancer Care Comes in a Pill

There are 2 comments on the New York Times story from Apr 14, 2009, titled Insurance Lags as Cancer Care Comes in a Pill. In it, New York Times reports that:

Chuck Stauffer's insurance covered the surgery to remove his brain tumor . It covered his brain scans.

Join the discussion below, or Read more at New York Times.

Since: Dec 05

Irvington, NJ

#1 Apr 15, 2009
Tykerb is another oral agent with the potential to compete directly with the IV drugs which is both a high-volume and high-revenue part of office-based practices. Although oral tyrosine kinase inhibitors, like Tykerb, offer patients a well-tolerated, conveniently administered alternative to intravenous (IV) therapy, Decisions Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, found that oncologists are not yet ready to use Tykerb as a replacement for Herceptin. Ninety-one percent of surveyed oncologists stated that intravenous (IV) cancer therapies are more profitable than oral therapies. And fifty-eight percent of oncologists say they would favor IV Herceptin over oral Tykerb because administration of IV drugs remains an important source of income for their practices.

The FDA finds themselves under increasing pressure to allow new drugs into the marketplace, while at the same time protecting the safety of potential recipients of those drugs and also the financial interests of those who will have to pay for them. The pressure is so great that companion molecular diagnostics approved often have been mostly or totally ineffective at identifying clinical responders (durable and otherwise) to the various therapies.

It should be in the FDA's interest in saving the healthcare system perhaps billions of dollars a year by ensuring that expensive treatments are used appropriately. It should serve their interest not only in discovering new cancer treatments, but also using currently-available cell culture assay technologies to improve the effectiveness of existing drugs and save lives today by administering the right drug to the right patient at the right time.

Technologies, developed over the last twenty years by private researchers, hold the key to solving some of the problems confronting a healthcare system that is seeking ways to best allocate available resources while accomplishing the critical task of matching individual patients with the treatments most likely to benefit them.
Jon
#2 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News 5 simple habits that can reduce your risk of br... Feb 6 Climb every mountain 1
News Autistic twins from Fitchburg will be losing th... Jan 31 Feel good story 1
AI in the clinical setting Jan '18 Curious 1
Giving Hematology-Oncology Patients the Best Ch... Jan '18 Fridha 1
Gut microbiotic bacteria wanted Jan '18 Happygolucky65 1
News SALTER: After an unexpected interruption, let's... Jan '18 Paid To Publish 4
News Mini-Vows: Something Clicked and a Long-Distanc... Dec '17 Brice N Livingston 1
More from around the web